Teperman L, Moonka D, Sebastian A, Sher L, Marotta P, Marsh C, Koneru B, Goss J, Preston D, Roberts JP; Spare-the-Nephron Trial Liver Transplantation Study Group. Calcineurin inhibitor-free mycophenolate mofetil/sirolimus maintenance in liver transplantation: the randomized spare-the-nephron trial. Liver Transpl 2013 Jul; 19 (7): 675-89.

Ali A, Bhardwaj HL, Heuman DM, Jovin IS. Coronary events in patients undergoing orthotopic liver transplantation: perioperative evaluation and management. Clin Transplant 2013 May; 27 (3): E207-15. doi: 10.1111/ctr.12113. Epub 2013 Mar 17.

Bárcena R, Moreno A, Rodríguez-Gandía MA, Albillos A, Arocena C, Blesa C, García-Hoz F, Graus J, Nuño J, López-Hervás P, Gajate L, Martínez A, Bermejo T, Mateos ML, Del Campo S. Safety and anti-HCV effect of prolonged intravenous silibinin in HCV genotype 1 subjects in the immediate liver transplant period; Hospital Ramón y Cajal. Liver Transplant Group. J Hepatol 2013 Mar; 58 (3): 421-6.

Reperfusion of liver graft during transplantation: techniques used in transplant centres within Eurotransplant and meta-analysis of the literature. Transpl Int. 2013 May;26(5):508-16.

Manzini G, Kremer M, Houben P, Gondan M, Bechstein WO, Becker T, Berlakovich GA, Friess H, Guba M, Hohenberger W, Ijzermans JN, Jonas S, Kalff JC, Klar E, Klempnauer J, Lerut J, Lippert H, Lorf T, Nadalin S, Nashan B, Otto G, Paul A, Pirenne J, Pratschke J, Ringers J, Rogiers X, Schilling MK, Seehofer D, Senninger N, Settmacher U, Stippel DL, Tscheliessnigg K, Ysebaert D, Binder H, Schemmer P, Turner AP, Knechtle SJ. Induction immunosuppression in liver transplantation: a review. Transpl Int 2013 May 8.

Honda M, Asonuma K, Hayashida S, Suda H, Ohya Y, Lee KJ, Yamamoto H, Takeichi T, Inomata Y. Incidence and risk factors for new-onset diabetes in living-donor liver transplant recipients. Clin Transplant 2013 Mar 7. doi: 10.1111/ctr.12103

Watt KD, Dierkhising R, Heimbach JK, Charlton MR. Impact of sirolimus and tacrolimus on mortality and graft loss in liver transplant recipients with or without hepatitis C virus: an analysis of the Scientific Registry of Transplant Recipients Database. Liver Transpl 2012 Sep; 18 (9): 1029-36

Abecassis M, Bridges ND, Clancy CJ, Dew MA, Eldadah B, Englesbe MJ, Flessner MF, Frank JC, Friedewald J, Gill J, Gries C, Halter JB, Hartmann EL, Hazzard WR, Horne FM, Hosenpud J, Jacobson P, Kasiske BL, Lake J, Loomba R, Malani PN, Moore TM, Murray A, Nguyen MH, Powe NR, Reese PP, Reynolds H, Samaniego MD, Schmader KE, Segev DL, Shah AS, Singer LG, Sosa JA, Stewart ZA, Tan JC, Williams WW, Zaas DW, High KP. Solid-organ transplantation in older adults: current status and future research. Am J Transplant 2012 Oct; 12 (10): 2608

Doppler Sonography to Diagnose Venous Congestion in a Modified Right Lobe Graft After Living Donor Liver Transplantation

Chimerism and Tolerance in a Recipient of a Deceased-Donor Liver Transplant

Ischemic cholangiopathy following liver transplantation from donation after cardiac death donors

Cell-mediated rejection results in allograft loss after liver cell transplantation

One-step venous reconstruction for a right lobe graft with multiple venous orifices in living donor liver transplantation

Isolated liver and multivisceral transplantation for total parenteral nutrition–related end-stage liver disease

Liver and intestine transplantation in the United States, 1997-2006

Outcome of bowel perforation after pediatric liver transplantation